To investigate the relationship between DCTN2 and immunological responses, we used four established algorithms (Quantification of Tumour Immune Contexture from human RNA‐seq data [QUANTISEQ], Microenvironment Cell Populations counter [MCPcounter], Estimating the Proportion of Immune and Cancer cells [EPIC], and TIMER) to evaluate the relationship of pan‐cancer immune cell infiltration with DCTN2 expression. The gene discussed is DCTN2; the disease is cancer.